Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR2 |
Variant | V564L |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | FGFR2 V564L (also referred to as V565L from the FGFR2IIIb isoform) lies within the protein kinase domain of the Fgfr2 protein (UniProt.org). V564L results in increased Fgfr2 kinase activity in cell culture and has been shown to be associated with secondary resistance to FGFR inhibitors (PMID: 25169980), and therefore, is predicted to lead to a gain of Fgfr2 protein function. |
Associated Drug Resistance | Y |
Category Variants Paths |
FGFR2 mutant FGFR2 act mut FGFR2 V564L |
Transcript | NM_000141.5 |
gDNA | chr10:g.121496705C>G |
cDNA | c.1690G>C |
Protein | p.V564L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_001144916 | chr10:g.121487376C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
XM_024447887.1 | chr10:g.121488077C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
XM_024447887.2 | chr10:g.121488077C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
NM_000141.5 | chr10:g.121496705C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
NM_001144916.2 | chr10:g.121487376C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
NM_000141.4 | chr10:g.121496705C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
NM_000141 | chr10:g.121496705C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
NM_001144916.1 | chr10:g.121487376C>G | c.1690G>C | p.V564L | RefSeq | GRCh38/hg38 |
Molecular Profile | Protein Effect | Treatment Approaches |
---|---|---|
FGFR2 V564L | gain of function - predicted | FGFR Inhibitor (Pan) FGFR2 Inhibitor |
FGFR2 M537I FGFR2 V564L FGFR2 amp | ||
FGFR2 G542A FGFR2 V564L FGFR2 amp | ||
FGFR2 C382R FGFR2 N549D FGFR2 N549H FGFR2 N549K FGFR2 V564L |